{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:59:02Z","timestamp":1782482342510,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00277-022-04920-w","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T19:02:32Z","timestamp":1657911752000},"page":"1987-2000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing"],"prefix":"10.1007","volume":"101","author":[{"given":"Madhavi","family":"Maddali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Prakash","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathya","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elanthenral","family":"Sigamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Korula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia N","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Anbumalar","family":"Lionel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Selvarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Therese","family":"Manipadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-439X","authenticated-orcid":false,"given":"Poonkuzhali","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"7","key":"4920_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/leu.2014.3","volume":"28","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al (2014) CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28(7):1472\u20131477","journal-title":"Leukemia"},{"issue":"2\u20134","key":"4920_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21623996.2016.1248011","volume":"5","author":"SE Langabeer","year":"2016","unstructured":"Langabeer SE (2016) Chasing down the triple-negative myeloproliferative neoplasms: implications for molecular diagnostics. JAK-STAT 5(2\u20134):e1248011","journal-title":"JAK-STAT"},{"issue":"3","key":"4920_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","volume":"127","author":"JD Milosevic Feenstra","year":"2016","unstructured":"Milosevic Feenstra JD, Nivarthi H, Gisslinger H, Leroy E, Rumi E, Chachoua I et al (2016) Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood 127(3):325\u2013332","journal-title":"Blood"},{"key":"4920_CR4","doi-asserted-by":"publisher","unstructured":"Diaconnu C, Mambet C, Necula L, Gurban P, Matei L, Aldea-Pitica I et al (2017) Triple negative myeloproliferative neoplasms - sometimes driver mutations stay low-key in plain sight. Roman Biotechnol Lett 23(4). https:\/\/doi.org\/10.26327\/RBL2017.12","DOI":"10.26327\/RBL2017.12"},{"issue":"6","key":"4920_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jmoldx.2018.07.002","volume":"20","author":"RF McClure","year":"2018","unstructured":"McClure RF, Ewalt MD, Crow J, Temple-Smolkin RL, Pullambhatla M, Sargent R et al (2018) Clinical significance of DNA variants in chronic myeloid neoplasms: a report of the association for molecular pathology. J Mol Diagn 20(6):717\u2013737","journal-title":"J Mol Diagn"},{"issue":"3","key":"4920_CR6","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/HS9.0000000000000044.","volume":"2","author":"W Alduaij","year":"2018","unstructured":"Alduaij W, McNamara CJ, Schuh A et al (2018) Clinical utility of next-generation sequencing in the management of myeloproliferative neoplasms: a single-center experience. Hemasphere. 2(3):e44. https:\/\/doi.org\/10.1097\/HS9.0000000000000044. (Published 2018 May 4)","journal-title":"Hemasphere."},{"key":"4920_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100708","volume":"42","author":"J Lee","year":"2020","unstructured":"Lee J, Godfrey AL, Nangalia J (2020) Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice. Blood Rev 42:100708","journal-title":"Blood Rev"},{"issue":"3","key":"4920_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood-2015-07-661983","volume":"127","author":"X Cabagnols","year":"2016","unstructured":"Cabagnols X, Favale F, Pasquier F, Messaoudi K, Defour JP, Ianotto JC et al (2016) Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients. Blood 127(3):333\u2013342","journal-title":"Blood"},{"issue":"2","key":"4920_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2016000208","volume":"1","author":"A Tefferi","year":"2016","unstructured":"Tefferi A, Lasho TL, Finke CM, Elala Y, Hanson CA, Ketterling RP et al (2016) Targeted deep sequencing in primary myelofibrosis. Blood Adv 1(2):105\u2013111","journal-title":"Blood Adv"},{"key":"4920_CR10","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Myeloproliferative Neoplasms [Internet]. NCCN. 2022 [cited 16 June 2022]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpn.pdf"},{"issue":"5","key":"4920_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","volume":"32","author":"T Barbui","year":"2018","unstructured":"Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R et al (2018) Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia 32(5):1057\u20131069","journal-title":"Leukemia"},{"key":"4920_CR12","doi-asserted-by":"publisher","unstructured":"M. Maddali, U.P. Kulkarni, N. Ravindra, et al., Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: a single-center experience from India. Hematol Oncol Stem Cell Ther. https:\/\/doi.org\/10.1016\/j.hemonc.2021.03.002","DOI":"10.1016\/j.hemonc.2021.03.002"},{"key":"4920_CR13","doi-asserted-by":"publisher","unstructured":"Freed D, Aldana R, Weber JA, Edwards JS. The Sentieon Genomics Tools - A fast and accurate solution to variant calling from next-generation sequence data [Internet]. Bioinformatics; 2017 Mar [cited 2021 Nov 24]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/115717","DOI":"10.1101\/115717"},{"issue":"D1","key":"4920_CR14","doi-asserted-by":"publisher","first-page":"D745","DOI":"10.1093\/nar\/gky1113","volume":"47","author":"F Cunningham","year":"2019","unstructured":"Cunningham F, Achuthan P, Akanni W, Allen J, Amode MR, Armean IM et al (2019) Ensembl 2019. Nucleic Acids Res 47(D1):D745\u2013D751","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4920_CR15","doi-asserted-by":"publisher","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","volume":"46","author":"DR Zerbino","year":"2018","unstructured":"Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J et al (2018) Ensembl 2018. Nucleic Acids Res 46(D1):D754\u2013D761","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"4920_CR16","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S et al (2012) A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics 28(21):2747\u20132754","journal-title":"Bioinformatics"},{"issue":"D1","key":"4920_CR17","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862\u2013D868","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"4920_CR18","first-page":"D514","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33(suppl_1):D514-7","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"4920_CR19","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C et al (2019) The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47(D1):D1005\u2013D1012","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4920_CR20","doi-asserted-by":"publisher","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","volume":"42","author":"D Welter","year":"2014","unstructured":"Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H et al (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42(D1):D1001\u2013D1006","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4920_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NST et al (2003) Human Gene Mutation Database (HGMD\u00ae): 2003 update. Hum Mutat 21(6):577\u2013581","journal-title":"Hum Mutat"},{"issue":"6","key":"4920_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/bioinformatics\/btq028","volume":"26","author":"A Mottaz","year":"2010","unstructured":"Mottaz A, David FPA, Veuthey A-L, Yip YL (2010) Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar. Bioinformatics 26(6):851\u2013852","journal-title":"Bioinformatics"},{"issue":"7571","key":"4920_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR et al (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374","journal-title":"Nature"},{"issue":"7616","key":"4920_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al (2016) analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285\u2013291","journal-title":"Nature"},{"issue":"1","key":"4920_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308\u2013311","journal-title":"Nucleic Acids Res"},{"key":"4920_CR26","unstructured":"gnomAD [Internet]. [cited 2022 Feb 24]. Available from: https:\/\/gnomad.broadinstitute.org\/"},{"issue":"Web Server Issu","key":"4920_CR27","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40(Web Server Issue):W452-7. https:\/\/doi.org\/10.1093\/nar\/gks539","journal-title":"Nucleic Acids Res."},{"key":"4920_CR28","doi-asserted-by":"publisher","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7:Unit7.20. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76.","DOI":"10.1002\/0471142905.hg0720s76"},{"issue":"4","key":"4920_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362","journal-title":"Nat Methods"},{"issue":"9","key":"4920_CR30","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1101\/gr.092619.109","volume":"19","author":"S Chun","year":"2009","unstructured":"Chun S, Fay JC (2009) Identification of deleterious mutations within three human genomes. Genome Res 19(9):1553\u20131561","journal-title":"Genome Res"},{"key":"4920_CR31","unstructured":"Cosmic. COSMIC - catalogue of somatic mutations in cancer [Internet]. [cited 2022 Feb 24]. Available from: https:\/\/cancer.sanger.ac.uk\/cosmic"},{"key":"4920_CR32","unstructured":"Integrative Genomics Viewer - PMC [Internet]. [cited 2022 Feb 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC3346182\/"},{"issue":"11","key":"4920_CR33","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35(11):1978\u20131980","journal-title":"Bioinformatics"},{"issue":"6","key":"4920_CR34","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","volume":"120","author":"F Passamonti","year":"2012","unstructured":"Passamonti F, Thiele J, Girodon F, Rumi E, Carobbio A, Gisslinger H et al (2012) A prognostic model to predict survival in 867 World Health Organization\u2013defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood 120(6):1197\u20131201","journal-title":"Blood"},{"issue":"9","key":"4920_CR35","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"F Passamonti","year":"2010","unstructured":"Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A et al (2010) A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115(9):1703\u20131708","journal-title":"Blood"},{"issue":"5","key":"4920_CR36","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet 17(5):405\u2013424","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"4920_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/jclinpath-2020-206570","volume":"74","author":"O Michail","year":"2021","unstructured":"Michail O, McCallion P, McGimpsey J et al (2021) Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. J Clin Pathol 74:808\u2013811","journal-title":"J Clin Pathol"},{"issue":"10","key":"4920_CR38","doi-asserted-by":"publisher","first-page":"E264","DOI":"10.1002\/ajh.25580","volume":"94","author":"P Acha","year":"2019","unstructured":"Acha P, Xandri M, Fuster-Tormo F, Palomo L, Xicoy B, Cabez\u00f3n M et al (2019) Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms. Am J Hematol 94(10):E264\u2013E267","journal-title":"Am J Hematol"},{"issue":"8","key":"4920_CR39","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1038\/bcj.2016.75","volume":"6","author":"A Angona","year":"2016","unstructured":"Angona A, Fern\u00e1ndez-Rodr\u00edguez C, Alvarez-Larr\u00e1n A, Camacho L, Longar\u00f3n R, Torres E et al (2016) Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing. Blood Cancer J 6(8):e463\u2013e463","journal-title":"Blood Cancer J"},{"issue":"10","key":"4920_CR40","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00277-019-03766-z","volume":"98","author":"A Alvarez-Larr\u00e1n","year":"2019","unstructured":"Alvarez-Larr\u00e1n A, L\u00f3pez-Guerra M, Rozman M, Correa J-G, Hern\u00e1ndez-Boluda JC, Tormo M et al (2019) Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis. Ann Hematol 98(10):2319\u20132328","journal-title":"Ann Hematol"},{"issue":"5","key":"4920_CR41","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/bloodadvances.2020003444","volume":"5","author":"D Luque Paz","year":"2021","unstructured":"Luque Paz D, Riou J, Verger E, Cassinat B, Chauveau A, Ianotto J-C et al (2021) Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood Adv 5(5):1442\u20131451","journal-title":"Blood Adv"},{"issue":"8","key":"4920_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29062","volume":"68","author":"H Batis","year":"2021","unstructured":"Batis H, Almugairi A, Almugren O, Aljabry M, Alqahtani F, Elbashir E et al (2021) Detrimental variants in MPIG6B in two children with myelofibrosis: does immune dysregulation contribute to myelofibrosis? Pediatr Blood Cancer 68(8):e29062","journal-title":"Pediatr Blood Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04920-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T05:24:34Z","timestamp":1660368274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04920-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4920"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04920-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study is a retrospective analysis using DNA extracted from EDTA blood samples collected for routine molecular diagnostics in our institution from patients suspected of myeloproliferative neoplasms. No additional personal or clinical details were collected from any patient for this study. All procedures performed in this study involving human participants were as per the ethical standards of the institutional research committee. The research and the laboratory tests have been conducted following the World Medical Association Code of Ethics (Declaration of Helsinki, 1964).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statements"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}